The use of azathioprine to ameliorate post-treatment encephalopathy associated with African trypanosomiasis

Hunter, C. A., Jennings, F. W., Kennedy, P. G. E. and Murray, M. (1992) The use of azathioprine to ameliorate post-treatment encephalopathy associated with African trypanosomiasis. Neuropathology and Applied Neurobiology, 18(6), pp. 619-625. (doi:10.1111/j.1365-2990.1992.tb00833.x)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1111/j.1365-2990.1992.tb00833.x

Abstract

The treatment of human African sleeping sickness is complicated by a post-treatment meningo-encephalitis that may be fatal. Using a mouse model this study assesses the use of the non-steroidal anti-inflammatory drug, azathioprine, in the management of this post-treatment reaction. Female NIH mice treated with the trypanocidal compound diminazene aceturate (40 mg/kg), 28 days after infection, developed a similar post-treatment reaction to that seen in humans. Administration of azathioprine (100 mg/kg) for 5 days before and 5 days after trypanocidal chemotherapy abrogated the pathology in the central nervous system although this returned approximately 15 days after cessation of azathioprine. Activated astrocytes associated with the later stages of the infection did not appear to be affected by the use of azathioprine.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Kennedy, Professor Peter and Murray, Professor Max
Authors: Hunter, C. A., Jennings, F. W., Kennedy, P. G. E., and Murray, M.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Neuropathology and Applied Neurobiology
Publisher:Wiley
ISSN:0305-1846
ISSN (Online):1365-2990

University Staff: Request a correction | Enlighten Editors: Update this record